Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device
NCT ID: NCT05425108
Last Updated: 2022-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
45 participants
INTERVENTIONAL
2022-06-23
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Projected Peripheral Defocus Using a Wearable Device
NCT04415684
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
NCT04080128
Effects of Projected Peripheral Defocus on Ocular Biometrics
NCT04388020
A Trial of Bifocals in Myopic Children With Esophoria
NCT00000128
Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia
NCT05438615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CP1 device
Binocular CP1
Binocular active projection of defocused image in the peripheral visual field
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Binocular CP1
Binocular active projection of defocused image in the peripheral visual field
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* visual acuity of at least 20/25 in each eye
Exclusion Criteria
* active ocular infection
* any prior history or participation in myopia control treatments within the past 3 months
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kubota Vision Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arkady Selenow, OD
Role: PRINCIPAL_INVESTIGATOR
Manhattan Vision Associates/Institute of Vision Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manhattan Vision Associates/Institute of Vision Research
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Study Coordinator
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP1 Pilot
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.